Mylan Institutional, Inc. recalls
2 notices naming Mylan Institutional, Inc. as the recalling firm, since December 18, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Potency
Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 1 more
Hazard (FDA): Super-Potent Drug: Out of specification potency results were obtained.
FDAMedicines
Mylan Institutional, Inc.: Levothyroxine Sodium Tablets and 5 more
Hazard (FDA): Subpotent and Superpotent Drug
FDAMedicines